![LyondellBasell Industries N.V. Website](https://cdn.finchat.io/792424.png)
LyondellBasell Industries N.V.
NYSE-LYB
Company Overview
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products; polyolefins; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; and polypropylene (PP) products, such as PP homopolymers and copolymers. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, acetyls, ethylene glycols, and ethylene oxides and derivatives. In addition, it produces and markets compounds and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders; and advanced polymers. Further, the company refines crude oil and other crude oils of varied types and sources into gasoline and distillates; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts. LyondellBasell Industries N.V. was incorporated in 2009 and is headquartered in Houston, Texas.
Name
LyondellBasell Industries N.V.
CEO
Mr. Peter Z. E. Vanacker
Website
www.lyondellbasell.com
Sector
Chemicals
Year Founded
2009
Profile
Market Cap
$30.63B
EV
$40.68B
Shares Out
325.09M
Revenue
$41.04B
Employees
20,000
Margins
Gross
12.21%
EBITDA
11.31%
Operating
7.88%
Pre-Tax
6.93%
Net
5.66%
FCF
6.24%
Returns (5Yr Avg)
ROA
9.4%
ROTA
33.57%
ROE
31.13%
ROCE
15.78%
ROIC
13.51%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$105.98
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$2,857M
Net Debt
$9,918M
Debt/Equity
0.94
EBIT/Interest
6.47
Growth (CAGR)
Rev 3Yr
5.09%
Rev 5Yr
2.17%
Rev 10Yr
-1.04%
Dil EPS 3Yr
-16.55%
Dil EPS 5Yr
-5.72%
Dil EPS 10Yr
-0.59%
Rev Fwd 2Yr
-7.81%
EBITDA Fwd 2Yr
3.02%
EPS Fwd 2Yr
4.7%
EPS LT Growth Est
-2.57%
Dividends
Yield
—
Payout
71.37%
DPS
$5.09
DPS Growth 3Yr
5.95%
DPS Growth 5Yr
4.68%
DPS Growth 10Yr
7.81%
DPS Growth Fwd 2Yr
4.62%